MARKET

INCR

INCR

Intercure Ltd.
NASDAQ
3.750
+0.010
+0.27%
After Hours: 3.750 0 0.00% 18:26 01/27 EST
OPEN
3.740
PREV CLOSE
3.740
HIGH
3.800
LOW
3.670
VOLUME
61.91K
TURNOVER
0
52 WEEK HIGH
8.20
52 WEEK LOW
3.270
MARKET CAP
169.25M
P/E (TTM)
16.88
1D
5D
1M
3M
1Y
5Y
InterCure: Why The Company Is Grossly Undervalued By Wall Street
Seeking Alpha · 01/20 17:22
Cannabis Is A Long-Term Play (Podcast Transcript)
Seeking Alpha · 01/09 11:30
Cannabis Is A Long-Term Play
Seeking Alpha · 01/04 15:30
Cannabis REITs: Smoked Out
Seekingalpha · 12/29/2022 16:15
Investing In The New Cannabis World After A Terrible 2022
Seekingalpha · 12/27/2022 13:30
InterCure Teams Up Wit Praetorian Global To License, Manufacture And Distribute Cannabis Brand 'Binske'
Benzinga · 12/19/2022 15:50
InterCure Announces Exclusive International Partnership Agreement With Award Winning Cannabis Brand "Binske"
Benzinga · 12/19/2022 13:42
InterCure to Participate in Cowen 5th Annual Cannabis Conference
Mr. Rabinovitch is one of the global cannabis senior executives to participateNEW YORK and TORONTO and HERZLIYA, Israel, Dec. 08, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) ...
GlobeNewswire · 12/08/2022 14:30
More
About INCR
InterCure Ltd is an Israel-based company primarily enagged in cannabis industry. Thorugh its wholly owned subsidiary Canndoc the Company operates as licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products.

Webull offers kinds of InterCure Ltd stock information, including NASDAQ:INCR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, INCR stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading INCR stock methods without spending real money on the virtual paper trading platform.